Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic Syndrome

NCT04818723 is registered in ClinicalTrials.gov with Nishtar Medical University as lead sponsor.

NCT NCT04818723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04818723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic Syndrome
Lead sponsor
Nishtar Medical University
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2019
Completion date
May 30, 2020
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nephrotic syndrome